The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Swedish study of 100,000 women found higher rate of early detection, suggesting potential to support radiologists The use of artificial intelligence in breast cancer screening reduces the rate of a ...

Prospective monitoring of prostate specific membrane antigen–positive biochemically recurrent prostate cancer (PSMA+ BCR): Preliminary data from 6-month PSMA follow-up.